Module 2 - IL-17 inhibitors in ax-SpA
This module examines IL-17 inhibitors and their application in the management of ax-SpA.
Evan Siegel, MD, FACP, FACR
Assistant Clinical Professor of Medicine
Georgetown University School of Medicine
Medical Director, Arthritis and Rehabilitation Services
Arthritis and Rheumatism Associates
Rockville, MD
Atul Deodhar, MD, FACP, FACR
Professor of Medicine
Division of Arthritis and Rheumatic Diseases
Medical Director, Rheumatology Clinics
Oresgon Health & Science University
Portland, OR
1.
Apply the latest clinical evidence for IL-17 antagonists for the management of SpA conditions
2.
Develop strategies to optimize the shared decision-making efforts and collaboration across the multidisciplinary care team in the management of SpA conditions
